ArticleCureus2025
Cannabis Use During Pregnancy Correlates With Adverse Maternal Mental Health Outcomes: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Self-Reported Cannabis Use in Pregnancy and Maternal Psychological Health.Cannabis (Albuquerque, N.M.) · 2026Article
- Racial Differences in Prenatal Cannabis Screening Among Women at Elevated Risk for Substance Use and Sexually Transmitted Infections.Journal of midwifery & women's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction The prevalence of cannabis use during pregnancy has risen alongside its legalization and perceived safety, often being used to alleviate pregnancy-related discomforts. However, cannabis use during pregnancy may have adverse implications for maternal mental health, including increased rates of depression, panic disorder, suicidal ideation, and alcohol abuse. This study aims to evaluate the association between cannabis use during pregnancy and these mental health outcomes. Methods This retrospective cohort study utilized the TriNetX database, including over 2 million pregnant patients from 69 U.S. healthcare organizations (HCOs). A cohort of 51,087 cannabis users during pregnancy was compared to 1,936,508 non-users. Outcomes analyzed included depression, panic disorder, suicidal ideation, and alcohol abuse, identified using the International Classification of Diseases, 10th Revision (ICD-10) codes. Risk ratios, hazard ratios, and Kaplan-Meier survival probabilities were calculated, with statistical significance set at p < 0.05. Results Cannabis use during pregnancy was associated with higher incidences of all four mental health outcomes. Alcohol abuse showed the greatest relative risk (risk ratio = 13.57; hazard ratio = 12.44), followed by suicidal ideation (risk ratio = 10.67; hazard ratio = 9.81), panic disorder (risk ratio = 5.47; hazard ratio = 5.01), and depression (risk ratio = 2.66; hazard ratio = 3.50). Depression affected 29.7% of cannabis users, compared to 11.2% of non-users, with significant differences in survival probabilities (p < 0.001). Conclusion Cannabis use during pregnancy is significantly associated with increased risks of adverse mental health outcomes. These findings emphasize the importance of screening for cannabis use and mental health conditions during pregnancy and underscore the need for public health initiatives addressing the risks of prenatal cannabis use. Further research is needed to explore causal relationships and dosing effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.